Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
7.42
+0.10 (1.37%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $43.47 million as of April 29, 2025. Its market cap has decreased by -48.92% in one year.
Market Cap
43.47M
Enterprise Value
46.41M
1-Year Change
-48.92%
Ranking
Category
Stock Price
$7.42
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $43.47M, a decrease of -79.81%. That is a compound annual growth rate of -14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 43.50M | -43.29% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |